ClinicalTrials.Veeva

Menu

Changes in Body Composition When Ingesting a Dairy Compound Enriched With Leucine (LEUCI)

U

Universidad Católica San Antonio de Murcia

Status

Completed

Conditions

Elderly Person
Physical Exercise
Body Composition

Treatments

Dietary Supplement: dietary supplement consumption

Study type

Interventional

Funder types

Other

Identifiers

NCT04345237
UCAMCFE-00013

Details and patient eligibility

About

Controlled clinical trial, randomized by strata (sex and period of the study), with 6 parallel branches to the study depending on the type of product consumed and the type of physical exercise program performed, double-blind masked for the consumption of the product and single-center.

Full description

The subjects that meet the selection criteria will make a total of seven visits to the research laboratory (two of them to collect product) and will carry out the pre-established tests in the protocol. Subsequently, a statistical analysis will be carried out with the variables measured in the study to obtain results.

Enrollment

142 patients

Sex

All

Ages

55 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects of both sexes with age between 55-70 years.
  • Body mass index less than 35.
  • Subjects who have given written informed consent to participate in the study.

Exclusion criteria

  • Consumption during the 6 months prior to the study of functional food enriched with leucine or nutritional supplement based on protein concentrate or that presents in its chemical composition leucine.
  • Presence of absolute or relative contraindications ruled by the American College of Sports Medicine (ACSM, 1995), during the performance of stress tests.
  • Presence of chronic diseases that prevent the performance of a physical exercise program or an exercise test (disabling arthropathies, moderate / severe chronic lung diseases, ischemic heart disease under treatment, arrhythmias, etc).
  • Abuse in the ingestion of alcohol.
  • Present hypersensitivity or intolerance to any of the components of the products under study.
  • Inability to understand informed consent.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

142 participants in 6 patient groups

Experimental group 1 (TS + placebo)
Experimental group
Description:
Training twice a week, with wave periodization. Traditional training (TS) in two circuits. Each exercise is separated by a rest period of 3 minutes and 5 minutes between circuits. Daily consumption for 3 months of placebo milk.
Treatment:
Dietary Supplement: dietary supplement consumption
Experimental group 2 (TS + leucine)
Experimental group
Description:
Training twice a week, with wave periodization. Traditional training (TS) in two circuits. Each exercise is separated by a rest period of 3 minutes and 5 minutes between circuits. Daily consumption for 3 months of milk enriched with leucine.
Treatment:
Dietary Supplement: dietary supplement consumption
Experimental group 3 (HRC + placebo)
Experimental group
Description:
Training twice a week, with wave periodization. High intensity training (HRC) on two circuits. Each exercise is separated by a rest period of 35 seconds and 5 minutes between circuits. Daily consumption for 3 months of placebo milk.
Treatment:
Dietary Supplement: dietary supplement consumption
Experimental group 4 (HRC + leucine)
Experimental group
Description:
Training twice a week, with wave periodization. High intensity training (HRC) on two circuits. Each exercise is separated by a rest period of 35 seconds and 5 minutes between circuits. Daily consumption for 3 months of milk enriched with leucine.
Treatment:
Dietary Supplement: dietary supplement consumption
Experimental group 5 (no physical exercise + leucine)
Experimental group
Description:
The subjects will not carry out any type of physical activity. Daily consumption for 3 months of milk enriched with leucine.
Treatment:
Dietary Supplement: dietary supplement consumption
Control (no physical exercise + placebo)
No Intervention group
Description:
The subjects will not carry out any type of physical activity. Daily consumption for 3 months of placebo milk.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems